» Articles » PMID: 28892787

Hepatoprotective Effects of Crocin on Biochemical and Histopathological Alterations Following Acrylamide-induced Liver Injury in Wistar Rats

Overview
Date 2017 Sep 12
PMID 28892787
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the present study is the treatment of oxidative damage caused by acrylamide induced oxidative stress in rats with the administration of a strong antioxidant, namely crocin. High acrylamide (AA) levels have genotoxic, carcinogenic and neurotoxic effects on living organisms. In the present study, 40 Wistar rats were randomly divided into four equal groups. These groups were control, acrylamide (25mg/kg), crocin (50mg/kg), acrylamide+crocin (25mg/kg acrylamide and 50mg/kg crocin) groups. At the end of the application, biochemical and histological variations were examined in liver and blood samples. It was observed that acrylamide administration significantly decreased liver GSH and TAS levels when compared to the control group. On the contrary, it was also observed that AST, ALT, ALP, SOD and CAT activities and TOS and MDA levels increased as a result of acrylamide administration. Histopathological examinations demonstrated inflammatory cell infiltration, hepatocellular necrosis and hemorrhage areas in AA group liver sections. Furthermore, intracytoplasmic vacuolization was detected in hepatocytes. After crocin treatment, it was observed that GSH and TAS levels increased while AST, ALT, ALP, SOD and CAT activities and TOS and MDA levels decreased. Significant decreases were observed in inflammatory cell infiltration and vascular congestion in liver sections and intracytoplasmic vacuolization in hepatocytes after the crocin treatment, while no hepatocellular necrosis and hemorrhages were observed. In the present study, it was demonstrated that crocin treatment removed acrylamide induced liver damage due to the strong antioxidant properties of crocin.

Citing Articles

A comprehensive review of medicinal plants and their beneficial roles in alleviating bisphenol A-induced organ toxicity.

Dolatabadi S, Oskuei S, Mehri S, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39932506 DOI: 10.1007/s00210-025-03795-8.


Effects of dietary acrylamide on kidney and liver health: Molecular mechanisms and pharmacological implications.

Quasmi M, Kumar D, Jangra A Toxicol Rep. 2025; 14:101859.

PMID: 39758802 PMC: 11699442. DOI: 10.1016/j.toxrep.2024.101859.


Acrylamide-targeting renal miR-21a-5p/Fibrotic and miR122-5p/ inflammatory signaling pathways and the role of a green approach for nano-zinc detected via and approaches.

Alqahtani L, Alosaimi M, Mohamed A, Abd-Elhakim Y, Khamis T, Noreldin A Front Pharmacol. 2024; 15:1413844.

PMID: 39086388 PMC: 11289894. DOI: 10.3389/fphar.2024.1413844.


Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male....

El-Megharbel S, Qahl S, Albogami B, Hamza R PeerJ. 2024; 12:e15638.

PMID: 38188145 PMC: 10768679. DOI: 10.7717/peerj.15638.


Rutin mitigates perfluorooctanoic acid-induced liver injury via modulation of oxidative stress, apoptosis, and inflammation.

Naderi M, Seyedabadi M, Talebpour Amiri F, Akbari S, Shaki F Iran J Basic Med Sci. 2023; 26(11):1291-1297.

PMID: 37886008 PMC: 10598813. DOI: 10.22038/IJBMS.2023.69747.15187.